Five drug companies recently urged the federal appeals court in Washington, D.C. to overturn a lower court's ruling on 340B rebates.

Drugmakers Argue HHS Cannot Reject 340B Rebates in Federal Appeals Court Briefs

September 3, 2025 William Newton, Associate Editor/Senior Writer Views

Five drug companies are pressing a federal appeals court to rule that the 340B statute does not give the government [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!